The Role and Mechanism of Nicotinamide Riboside in Oxidative Damage and a Fibrosis Model of Trabecular Meshwork Cells

Author:

Zeng Yuping1,Lin Yijun1234,Yang Juhua5,Wang Xiaohui1234,Zhu Yihua1234,Zhou Biting1234

Affiliation:

1. Department of Ophthalmology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China

2. Department of Ophthalmology, National Regional Medical Center, Binghai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China

3. Fujian Institute of Ophthalmology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China

4. Fujian Provincial Clinical Medical Research Center of Eye Diseases and Optometry, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China

5. Department of Bioengineering and Biopharmaceutics, School of Pharmacy, Fujian Medical University, Fuzhou, China

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Reference63 articles.

1. Systemic treatment with nicotinamide riboside is protective in two mouse models of retinal ganglion cell damage;Zhang;Pharmaceutics,2021

2. Glaucoma;Kang;Med Clin North Am,2021

3. Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension;Clement Freiberg;Cochrane Database Syst Rev,2022

4. Adherence to therapy in glaucoma treatment—a review;Zaharia;J Pers Med,2022

5. Miniaturization in glaucoma monitoring and treatment: a review of new technologies that require a minimal surgical approach;Dick;Ophthalmol Ther,2019

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3